In this regard, dosing every 2 weeks at 40 mg/kg still showed sustained tumor growth inhibition that was similar to 40 mg/kg dosed weekly, with comparable effects on the pharmacodynamic biomarkers SMARCA2 and KRT80 mRNA (Table 2). The gene discussed is SMARCA2; the disease is neoplasm.